Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Libera Ascierto

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|July 29, 2015
Melanoma: From Incurable Beast to a Curable Bet. The Success of ImmunotherapyMaria Libera Ascierto, Ignacio Melero, Paolo Antonio Ascierto
Frontiers in Immunology|July 30, 2014
Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCVFrancesco Marras, Federica Bozzano, Maria Libera Ascierto, et al.
International Journal of Molecular Sciences|May 14, 2025
Oncogenic Signalling Pathways in Cancer Immunotherapy: Leader or Follower in This Delicate Dance?Douglas Cartwright, Andrew C Kidd, Sonam Ansel, et al.
Cells|October 14, 2022
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells ActivityAlberto Mendoza-Valderrey, Maite Alvarez, Andrea De Maria, et al.
Journal of Translational Medicine|October 8, 2011
Distinct signatures of the immune responses in low risk versus high risk neuroblastomaMadhu Gowda, Kamar Godder, Maciej Kmieciak, et al.
Journal of Translational Medicine|October 16, 2009
Main roads to melanomaGiuseppe Palmieri, Mariaelena Capone, Maria Libera Ascierto, et al.
Cancer Medicine|August 9, 2024
Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancerAlberto Mendoza-Valderrey, Jane Choe, Daria M Kessler, et al.
Journal of Translational Medicine|April 2, 2011
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressureMaciej Kmieciak, Kyle K Payne, Michael O Idowu, et al.
Journal of Translational Medicine|September 19, 2015
Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastomaJennifer Johnson, Maria Libera Ascierto, Sandeep Mittal, et al.
Medical Oncology (Northwood, London, England)|May 24, 2012
Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American populationSara Tomei, Sharon Adams, Lorenzo Uccellini, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|July 29, 2015
Melanoma: From Incurable Beast to a Curable Bet. The Success of ImmunotherapyMaria Libera Ascierto, Ignacio Melero, Paolo Antonio Ascierto
Frontiers in Immunology|July 30, 2014
Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCVFrancesco Marras, Federica Bozzano, Maria Libera Ascierto, et al.
International Journal of Molecular Sciences|May 14, 2025
Oncogenic Signalling Pathways in Cancer Immunotherapy: Leader or Follower in This Delicate Dance?Douglas Cartwright, Andrew C Kidd, Sonam Ansel, et al.
Cells|October 14, 2022
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells ActivityAlberto Mendoza-Valderrey, Maite Alvarez, Andrea De Maria, et al.
Journal of Translational Medicine|October 8, 2011
Distinct signatures of the immune responses in low risk versus high risk neuroblastomaMadhu Gowda, Kamar Godder, Maciej Kmieciak, et al.
Journal of Translational Medicine|October 16, 2009
Main roads to melanomaGiuseppe Palmieri, Mariaelena Capone, Maria Libera Ascierto, et al.
Cancer Medicine|August 9, 2024
Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancerAlberto Mendoza-Valderrey, Jane Choe, Daria M Kessler, et al.
Journal of Translational Medicine|April 2, 2011
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressureMaciej Kmieciak, Kyle K Payne, Michael O Idowu, et al.
Journal of Translational Medicine|September 19, 2015
Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastomaJennifer Johnson, Maria Libera Ascierto, Sandeep Mittal, et al.
Medical Oncology (Northwood, London, England)|May 24, 2012
Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American populationSara Tomei, Sharon Adams, Lorenzo Uccellini, et al.
Pageof 3